Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox-Reference-Cited by-同舟云学术

Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox

Published:2009-04-24 Issue:11-12 Volume:36 Page:385-395
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:

Author:

Reitze H. K.,Dannhorn D. R.,Häne H.,Seitz K. A.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1439-0507.1993.tb00727.x/fullpdf

Reference20 articles.

1. Rilopirox, a new hydroxy-pyridone antifungal with fungicidal properties;Raether;Mycoses,1990

2. Mode of action of 6-cyclohexyl-l-hydroxy-4-methyl-2-(lH)-pyridone ethanolamine salt (HOE 296);Sakurai;Chemotherapy,1973

3. Studies on the mechanism of the antifungal action of ciclopirox olamine. Inhibition of transmembrane transport of amino acids, K +, and phosphate in Candida albicans cells;Iwata;Drug Res.,1981

4. Studies for the elucidation of the mode of action of the antimycotic hydroxypyridone compound rilopirox;Kruse;Pharmacology,1991

5. A low viscosy epoxy resin embedding medium for electron microscopy;Spurr;J. Ultrastr. Res.,1969

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic antifungal effect and potential mechanism of Dimethomorph combined with Pyrimethanil against Phytophthora capsici;Food Chemistry;2024-11

2. In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans;Mycoses;2006-05

3. MHP1, aMagnaporthe griseahydrophobin gene, is required for fungal development and plant colonization;Molecular Microbiology;2005-07-20

4. Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors;Antimicrobial Agents and Chemotherapy;2003-06

5. Wirkungsweise von Ciclopiroxolamin auf Candida albicans;Mycoses;2002-09